Risk factors for severe bacterial infections in patients with systemic autoimmune diseases receiving rituximab-Reference-Cited by-同舟云学术

Risk factors for severe bacterial infections in patients with systemic autoimmune diseases receiving rituximab

Published:2014-02-02 Issue: Volume: Page:
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Heusele Marion,Clerson Pierre,Guery Benoit,Lambert Marc,Launay David,Lefevre Guillaume,Morell-Dubois Sandrine,Maillard Hélène,Le Gouellec Noémie,Hatron Pierre-Yves,Hachulla Eric

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/s10067-014-2509-2.pdf

Reference21 articles.

1. Ramos-Casals M, Brito-Zerón P, Muñoz S, Soto MJ, Biogeas Study Group (2008) A systematic review of the off-label use of biological therapies in systemic autoimmune diseases. Medicine (Baltimore) 87:345–364

2. Stashenko P, Nadler LM, Hardy R, Schlossman SF (1980) Characterization of a human B lymphocyte-specific antigen. J Immunol 125:1678–1685

3. Keystone E, Fleischmann R, Emery P et al (2007) Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: an open-label extension analysis. Arthritis Rheum 56:3896–3908

4. St Clair EW (2010) Good and bad memories following rituximab therapy. Arthritis Rheum 62:1–5

5. Muhammad K, Roll P, Einsele H, Dörner T, Tony HP (2009) Delayed acquisition of somatic hypermutations in repopulated IGD+CD27+ memory B cell receptors after rituximab treatment. Arthritis Rheum 60:2284–2293

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypogammaglobulinemia and Infection Events in Patients with Autoimmune Diseases Treated with Rituximab: 10 Years Real-Life Experience;Journal of Clinical Immunology;2024-08-16

2. Disease-modifying therapies;Clinical Aspects of Multiple Sclerosis Essentials and Current Updates;2024

3. Risk Factors and Incidence of Serious Infections in Patients With Systemic Lupus Erythematosus Undergoing Rituximab Therapy;The Journal of Rheumatology;2023-10-15

4. Infectious risk when prescribing rituximab in patients with hypogammaglobulinemia acquired in the setting of autoimmune diseases;International Immunopharmacology;2023-07

5. Hypogammaglobulinemia, late-onset neutropenia, and infections following rituximab;Annals of Allergy, Asthma & Immunology;2023-06